Source: BioPortfolio

KineMed: KineMed Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 17092018 Prices from USD $250

SummaryKineMed Inc KineMed is a biotechnology company that develops and commercializes proprietary biomarker platform technology. The company applies its proprietary biomarker platform technology to drug development prescription and nonprescription medical...

Read full article »
Annual Revenue
$5.0-25M
Employees
25-100
David Fineman's photo - Chairman & CEO of KineMed

Chairman & CEO

David Fineman

CEO Approval Rating

69/100

Read more